Renal specific secondary hypertension.
Chronic kidney disease (CKD) is now understood to affect over 5% of all adult patients and it conveys a risk of reduced survival in those affected. At least 80% of those patients with stages 3-5 CKD (i.e. GFR <60 ml/min) suffer with hypertension, and in most the major cause is due to pertubation of an important renal endocrine system, the renin-angiotensin-aldosterone (RAA) axis. In this article the epidemiology of renal-related hypertension and its importance in pre-disposing to the increased cardiovascular risk in renal disease are discussed. Hypertension is known to be a major cause of progressive loss of renal function in CKD, particularly because of activation of the RAA, and hence the case for blockade of this system with ACE inhibitors and Angiotensin receptor blockers is highlighted.
Kalra
P A
PA
Hope Hospital, Salford, UK. philip.kalra@srht.nhs.uk
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000150:complications / Q000503:physiopathology; D018450:Disease Progression; D006801:Humans; D006977:Hypertension, Renal / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000503:physiopathology; D012306:Risk; D009626:Terminology as Topic; D006113:United Kingdom / Q000453:epidemiology
D000959:Antihypertensive Agents